The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
No significant effect on bone mineral density by high doses of vitamin D3 given to overweight subjects for one year
Open accessAbstract
BACKGROUND: In meta-analyses supplementation with vitamin D appears to reduce incidence of fractures, and in cross-sectional studies there is a positive association between serum 25-hydroxyvitamin D (25(OH)D) levels and bone mineral density (BMD). However, the effect of supplementation with high doses of vitamin D on BMD is more uncertain and could in theory have both positive and negative effects. METHODS: The study was a one year, double blind placebo-controlled intervention trial performed at the University Hospital of North Norway. 421 subjects, 21 - 70 years old, were included and 312 completed the study. The subjects were randomized to vitamin D3 40.000 IU per week (DD group), vitamin D3 20.000 IU per week (DP group), or placebo (PP group). All subjects were given 500 mg calcium daily. Serum 25(OH)D, osteoprotegrin (OPG), receptoractivator of nuclear factor-kappaB ligand (RANKL), and BMD at the lumbar spine and the hip were measured before and at the end of the study. RESULTS: At baseline the mean serum 25(OH)D levels were 58 nmol/L (all subjects) and increased to 141 and 100 nmol/L in the DD and DP groups, respectively. After one year, no significant differences were found between the three groups regarding change in BMD, serum OPG or RANKL. CONCLUSIONS: Supplementation with high doses of vitamin D for one year does not appear to have a negative effect on BMD in healthy subjects. In order to disclose a positive effect, subjects with low BMD and/or low serum 25(OH)D levels need to be studied. TRIAL REGISTRATION: The trial was registered at ClinicalTrials.gov (NCT00243256).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,228
Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes
Bischoff-Ferrari, H. A., Giovannucci, E., Willett, W. C., Dietrich, T., & Dawson-Hughes, B. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.1.18 · Cited by 2,414
Overview of general physiologic features and functions of vitamin D
DeLuca, H. F. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.6.1689s · Cited by 2,327
Functions of RANKL/RANK/OPG in bone modeling and remodeling
Boyce, B. F., & Xing, L. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.03.018 · Cited by 1,844 · cited 1×
“The osteoblasts also produce OPG which functions as a decoy receptor and binds RANKL and thereby prevents it from binding to RANK [2,7].”
BackgroundBischoff-Ferrari, H. A., Dietrich, T., Orav, E. J., & Dawson-Hughes, B. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.12.029 · Cited by 804
Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis.
Tsuda, E., Goto, M., Mochizuki, S.-I., Yano, K., Kobayashi, F., Morinaga, T., & Higashio, K. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6603 · Cited by 787
Bischoff-Ferrari, H. A., Willett, W. C., Wong, J. B., Stuck, A. E., Staehelin, H. B., Orav, E. J., Thoma, A., Kiel, D. P., & Henschkowski, J. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.600 · Cited by 776
Hofbauer, L. C., Khosla, S., Dunstan, C. R., Lacey, D. L., Spelsberg, T. C., & Riggs, B. L. (1999) · Endocrinology · doi:10.1210/endo.140.9.7131 · Cited by 692 · cited 1×
“Most likely oestrogen, as well as bisphosphonates, influence the production of OPG and RANKL as demonstrated in in-vitro studies [32,33].”
BackgroundThe urgent need to recommend an intake of vitamin D that is effective
Vieth, R., Bischoff-Ferrari, H., Boucher, B. J., Dawson-Hughes, B., Garland, C. F., Heaney, R. P., Holick, M. F., Hollis, B. W., Lamberg-Allardt, C., McGrath, J. J., et al. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.3.649 · Cited by 684
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Cited by 650
1,25-Dihydroxycholecalciferol: A Potent Stimulator of Bone Resorption in Tissue Culture
Raisz, L. G., Trummel, C. L., Holick, M. F., & Deluca, H. F. (1972) · Science · doi:10.1126/science.175.4023.768 · Cited by 628
Lee, S.-K., & Lorenzo, J. A. (1999) · Endocrinology · doi:10.1210/endo.140.8.6887 · Cited by 464
Vitamin D and disease prevention with special reference to cardiovascular disease
Zittermann, A. (2006) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2006.02.001 · Cited by 447
Viereck, V., Emons, G., Lauck, V., Frosch, K.-H., Blaschke, S., Gründker, C., & Hofbauer, L. C. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6510 · Cited by 310
Vega, D., Maalouf, N. M., & Sakhaee, K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0646 · Cited by 246
Rogers, A., & Eastell, R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0794 · Cited by 215 · cited 2×
“In other studies where serum OPG and RANKL have been measured after therapy, the results have varied [27].”
BackgroundResultSneve, M., Figenschau, Y., & Jorde, R. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0339 · Cited by 201
Self-citationSerum levels of osteoprotegerin increase with age in a healthy adult population.
Kudlacek, S., Schneider, B., Woloszczuk, W., Pietschmann, P., & Willvonseder, R. (2003) · Bone · doi:10.1016/s8756-3282(03)00090-5 · Cited by 187
Baldock, P. A., Thomas, G. P., Hodge, J. M., Baker, S. U., Dressel, U., O'Loughlin, P. D., Nicholson, G. C., Briffa, K. H., Eisman, J. A., & Gardiner, E. M. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060714 · Cited by 168
Shiraishi, A., Takeda, S., Masaki, T., et al. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.4.770 · Cited by 151
von Mühlen, D. G., Greendale, G. A., Garland, C. F., Wan, L., & Barrett-Connor, E. L. (2005) · Osteoporosis International · doi:10.1007/s00198-005-1910-8 · Cited by 108
Serum osteoprotegerin and its relationship with bone mineral density and markers of bone turnover.
Indridason, O. S., Franzson, L., & Sigurdsson, G. (2005) · Osteoporosis International · doi:10.1007/s00198-004-1699-x · Cited by 107
c-Fos protein as a target of anti-osteoclastogenic action of vitamin D, and synthesis of new analogs
Takasu, H., Sugita, A., Uchiyama, Y., Katagiri, N., Okazaki, M., Ogata, E., & Ikeda, K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24742 · Cited by 107
Kamycheva, E., Jorde, R., Figenschau, Y., & Haug, E. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03347410 · Cited by 75
Self-citationAlvarez, L., Peris, P., Guañabens, N., Vidal, S., Ros, I., Pons, F., Filella, X., Monegal, A., Muñoz‐Gomez, J., & Ballesta, A. M. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10834 · Cited by 66
Serum osteoprotegerin is inversely associated with carotid plaque echogenicity in humans
Vik, A., Mathiesen, E. B., Notø, A. W., Sveinbjørnsson, B., Brox, J. H., & Hansen, J. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.03.002 · Cited by 60
Self-citationCrisafulli, A., Altavilla, D., Squadrito, G., Romeo, A., Adamo, E. B., Marini, R., Inferrera, M. A., Marini, H. R., Bitto, A., D’Anna, R., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030891 · Cited by 56
Hofbauer, L. C., Schoppet, M., Schüller, P., Viereck, V., & Christ, M. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01969.x · Cited by 52
Osmančević, A., Nilsen, L. T. N., Landin‐Wilhelmsen, K., Søyland, E., Torjesen, P. A., Hagve, T., Nenseter, M. S., & Krogstad, A. (2009) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2009.03245.x · Cited by 52
Self-citationSneve, M., Emaus, N., Joakimsen, R. M., & Jorde, R. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0610 · Cited by 51
Self-citationValleala, H., Mandelin, J. M., Laasonen, L., Koivula, M.-K., Risteli, J., & Konttinen, Y. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480527 · Cited by 17
Ikeda, K. (2007) · Endocrine Journal · doi:10.1507/endocrj.kr-82 · Cited by 6
Cited by
Shahidi, F., & Ambigaipalan, P. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.06.018 · Cited by 3,081
Vegetarianism. A blossoming field of study
Ruby, M. B. (2012) · Appetite · doi:10.1016/j.appet.2011.09.019 · Cited by 887
Vitamin D supplementation for prevention of mortality in adults
Bjelakovic, G., Gluud, L. L., Nikolova, D., Whitfield, K., Wetterslev, J., Simonetti, R. G., Bjelakovic, M., & Gluud, C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007470.pub3 · Cited by 695
Effects of vitamin D supplements on bone mineral density: A systematic review and meta-analysis
Reid, I. R., Bolland, M. J., & Grey, A. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61647-5 · Cited by 678
Vitamin D for the prevention of disease: An Endocrine Society clinical practice guideline
Demay, M. B., Pittas, A. G., Bikle, D. D., Diab, D. L., Kiely, M. E., Lazaretti-Castro, M., Lips, P., Mitchell, D. M., Murad, M. H., Powers, S., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae290 · Cited by 639
Metadata
- Authors
- Jorde, R., Sneve, M., Torjesen, P. A., Figenschau, Y., Hansen, J.-B., & Grimnes, G.
- Venue
- Nutrition Journal
- Published
- 2010-01-07
- Volume
- 9
- Issue
- 1
- Pages
- 1-1
- ISSN
- 1475-2891 (ISSN-L)
- OpenAlex
- W2163139481
- Cited by
- 323
- References
- 34
- FWCI
- 14.23
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.